| reason | Number | Proportion (%) |
| Gynecological Indications (n = 108) |
|
|
| Uterine fibroids | 51 | 47.3 |
| Genital prolapse | 22 | 20.4 |
| Cervical dysplasia | 10 | 9.3 |
| Uterine cervical cancer stage I | 9 | 8.3 |
| Genital bleeding | 8 | 7.4 |
| Choriocarcinoma | 3 | 2.8 |
| Endometrial cancer | 1 | 0.9 |
| Ovarian cyst | 1 | 0.9 |
| Uterine malformation | 1 | 0.9 |
| Ovarian tumor | 1 | 0.9 |
| Uterine tumor | 1 | 0.9 |
| Obstetric Indications (n = 20) |
|
|
| Uterine rupture | 12 | 60 |
| Postpartum hemorrhage | 3 | 15 |
| Placenta praevia | 1 | 5 |
| Pre rupture uterine | 1 | 5 |
| acromion presentation | 1 | 5 |
| post ceasarean evisceration | 1 | 5 |
| Hydatiform mole | 1 | 5 |
| Total | 128 | 100 |